COVID-19 (SARS-Cov-2) and the heart - An ominous association.

MedStar author(s):
Citation: Cardiovascular Revascularization Medicine. 21(8):946-949, 2020 08.PMID: 32423791Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: *Betacoronavirus | *Coronavirus Infections/co [Complications] | *Glucocorticoids/tu [Therapeutic Use] | *Myocarditis/et [Etiology] | *Pandemics | *Pneumonia, Viral/co [Complications] | *ST Elevation Myocardial Infarction/et [Etiology] | *Thrombolytic Therapy/mt [Methods] | Adult | Coronary Angiography | Coronavirus Infections/ep [Epidemiology] | Echocardiography | Electrocardiography | Female | Humans | Male | Middle Aged | Myocarditis/di [Diagnosis] | Myocarditis/dt [Drug Therapy] | Pneumonia, Viral/ep [Epidemiology] | ST Elevation Myocardial Infarction/di [Diagnosis] | ST Elevation Myocardial Infarction/dt [Drug Therapy]Year: 2020Local holdings: Available in print through MWHC library: 2002 - presentISSN:
  • 1878-0938
Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiovascular manifestations of COVID-19 are diverse and complex and include acute coronary syndrome, myocarditis masquerading as ST-segment elevation myocardial infarction, pericarditis and pericardial effusion. We present 2 cases of COVID-19 infection with myocardial involvement with distinct mechanistic pathways and outcomes. Important decision strategies such as the timing of cardiac catheterization (when indicated) and requirement of early hemodynamic support in critically ill patients are discussed. Copyright (c) 2020 Elsevier Inc. All rights reserved.All authors: Ben-Dor I, Case BC, Chen Y, Khalid N, Rogers T, Shlofmitz E, Waksman R, Wermers JPOriginally published: Cardiovascular Revascularization Medicine. 2020 May 15Fiscal year: FY2021Fiscal year of original publication: FY2020Digital Object Identifier: Date added to catalog: 2020-07-09
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32423791 Available 32423791

Available in print through MWHC library: 2002 - present

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiovascular manifestations of COVID-19 are diverse and complex and include acute coronary syndrome, myocarditis masquerading as ST-segment elevation myocardial infarction, pericarditis and pericardial effusion. We present 2 cases of COVID-19 infection with myocardial involvement with distinct mechanistic pathways and outcomes. Important decision strategies such as the timing of cardiac catheterization (when indicated) and requirement of early hemodynamic support in critically ill patients are discussed. Copyright (c) 2020 Elsevier Inc. All rights reserved.

English

Powered by Koha